Brain Scientific Inc.
BRSF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -19.3% | 183.7% | -80.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 25.3% | 31.3% | 53.3% | 20.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $9 | $7 | $2 | $1 |
| SG&A Expenses | $9 | $8 | $3 | $1 |
| Sales & Mktg Exp. | $1 | $1 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $10 | $9 | $3 | $1 |
| Operating Income | -$10 | -$9 | -$3 | -$1 |
| % Margin | -4,478.1% | -3,257.4% | -2,956.8% | -198.3% |
| Other Income/Exp. Net | -$3 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$12 | -$9 | -$3 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$12 | -$9 | -$3 | -$1 |
| % Margin | -5,753% | -3,424.6% | -2,992.6% | -205.2% |
| EPS | -12.95 | -25.21 | -8.88 | -4.44 |
| % Growth | 48.6% | -183.9% | -100% | – |
| EPS Diluted | -12.95 | -25.21 | -8.88 | -4.44 |
| Weighted Avg Shares Out | 1 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 1 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $4 | $1 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $0 | $0 |
| EBITDA | -$8 | -$8 | -$3 | -$1 |
| % Margin | -3,697.6% | -3,132% | -2,938.3% | -198% |